Methods of diagnosing fetal trisomy 13 or a risk of fetal trisomy 13 during pregnancy

Details for Australian Patent Application No. 2006226891 (hide)

Owner Beth Israel Deaconess Medical Center

Inventors Karumanchi, S. Ananth

Agent Griffith Hack

Pub. Number AU-A-2006226891

PCT Pub. Number WO2006/102498

Priority 60/664,756 24.03.05 US

Filing date 24 March 2006

Wipo publication date 28 September 2006

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 33/567 (2006.01) Investigating or analysing materials by specific methods not covered by groups - utilising isolate of tissue or organ as binding agent

Event Publications

25 October 2007 PCT application entered the National Phase

  PCT publication WO2006/102498 Priority application(s): WO2006/102498

20 October 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006226897-Combinations for the treatment of cancer comprising anti-EGFR antibody and VEGFR inhibitors

2006226887-Nanoparticulate corticosteroid and antihistamine formulations